Stimulant Toxicity: Cocaine, Amphetamines and the Beta-Blocker Trap
Most poisons quieten the body — opioids slow the breath, sedatives dim the mind. Stimulants do the opposite: they turn the sympathetic nervous system up to a roar and leave it stuck there. The patient is hot, wired, pupils blown wide, heart racing against a soaring blood pressure. The danger is not just how ill they look but the quiet catastrophes underneath — a coronary in a twenty-year-old, a torn aorta, a bleed in the brain, muscle dissolving into the bloodstream. And there is a trap laid for the unwary doctor: the one obvious drug you reach for to slow that racing heart can kill the patient. Getting stimulant toxicity right is as much about what you must not give as what you do.
A 24-year-old man is dragged into the resuscitation room by friends after a night out. He is agitated to the point of thrashing, drenched in sweat, and speaking in a torrent no one can follow. His skin is burning — a core temperature of 40.5°C — his pupils are enormous, his heart rate 155, his blood pressure 210 over 120. He clutches his chest. The ECG shows a fast, broad-complex rhythm. Somewhere in the story is cocaine, and perhaps more than one drug. A junior instinct is to reach for a beta-blocker to break the tachycardia and hypertension — and that instinct, here, could be lethal. What this young man needs first is not a fancy antidote but something almost boringly simple: sedation with a benzodiazepine, aggressive cooling, and fluids — while the team hunts for the coronary, the torn vessel, or the bleed that stimulants love to cause.
One toxidrome, several drugs
Cocaine, amphetamines, cathinones and MDMA all end up flooding the synapse with the same messengers. Recreational stimulants are a family united by a final common effect: too much noradrenaline, dopamine and serotonin in the synaptic cleft, for too long. They reach it by two routes. Cocaine works mainly by blocking the reuptake transporters — the pumps that normally recycle these monoamines back into the neuron — so the transmitter that has already been released lingers and keeps signalling. Amphetamine and methamphetamine, the synthetic cathinones sold as "bath salts", and MDMA ("ecstasy") work the other way: they force the neuron to dump its stored monoamines out into the synapse (and also impede reuptake). Different mechanism, same result. MDMA leans especially hard on serotonin, which shapes both its euphoric character and its particular dangers. Whichever the drug, the receptors on the receiving end are the adrenergic and dopaminergic ones taught in the Autonomic nervous system chapter — this is a chemically driven overdrive of the sympathetic system.
Cocaine hides a second, more sinister trick that the pure releasers lack. Beyond blocking reuptake, it blocks fast cardiac sodium channels — the same membrane-stabilising, "local-anaesthetic" action that made it the first local anaesthetic ever used. In the heart this is not benign: slowing the sodium current widens the QRS complex and sets the stage for ventricular arrhythmia. This is exactly the mechanism you meet in tricyclic-antidepressant poisoning and in local-anaesthetic systemic toxicity, discussed in the Cardiovascular chapter — and, crucially, it points to the same antidote. So cocaine is really two poisons in one molecule: a sympathomimetic and a sodium-channel blocker.
Think of the nerve terminal as a bucket brigade passing water (monoamine) to a fire. Normally, once a bucket is thrown, it is caught and carried back to be refilled — that is reuptake. Cocaine snips the return rope: buckets pile up at the fire and the signal blazes. Amphetamine does something ruder — it kicks over the whole store of full buckets at once, flooding the line. Either way the fire — the sympathetic alarm — roars out of control. And benzodiazepines, the treatment, don't fight the water bucket by bucket; they turn down the alarm bell itself, the central drive telling the brigade to keep running.
The sympathomimetic storm
The clinical picture is the sympathetic nervous system in full cry — the sympathomimetic toxidrome. The patient is agitated, sometimes frankly psychotic and violent; the pupils are widely dilated (mydriasis); the heart races and the blood pressure climbs; the skin is hot, and — the single most useful bedside sign — soaking wet with sweat. Seizures may punctuate the picture. That sweat is the discriminator every exam loves. The anticholinergic toxidrome (from atropine, antihistamines, tricyclics) can look almost identical — agitated, tachycardic, dilated pupils, hot — but the anticholinergic patient is bone dry, because sweating is a cholinergic function they have blocked. "Sweaty and stimulated" points to sympathomimetic; "dry as a bone" points to anticholinergic. The two toxidromes are set side by side in the Toxidromes chapter for exactly this reason.
- Cocaine blocks reuptake of noradrenaline, dopamine and serotonin; amphetamines/methamphetamine, cathinones and MDMA force monoamine release.
- Cocaine also blocks fast cardiac sodium channels — a membrane-stabilising effect that widens QRS (the TCA/local-anaesthetic parallel).
- The sympathomimetic toxidrome: agitation, mydriasis, tachycardia, hypertension, hyperthermia, diaphoresis, seizures.
- Sweaty distinguishes sympathomimetic from the dry anticholinergic toxidrome — the classic bedside discriminator.
- MDMA leans heavily on serotonin, shaping both its effect and its distinctive complications.
Where stimulants actually kill
The vital signs frighten; the end-organ damage is what maims and kills. The heart takes the first blow. Stimulants cause myocardial ischaemia and infarction by a triple assault: coronary vasospasm, accelerated thrombosis (they make platelets stickier), and a soaring myocardial oxygen demand from the racing, hypertensive heart. A young cocaine user with crushing chest pain and an evolving MI is a classic and genuine emergency — managed along the lines of the acute-coronary-syndrome pathway in the Cardiovascular chapter, with the one large caveat about beta-blockers below. The great vessels are not spared: the surge in blood pressure and shear stress can tear the aorta (aortic dissection) or rupture a cerebral vessel, producing intracranial haemorrhage or ischaemic stroke — in patients decades younger than the usual victims of these catastrophes.
Then there is heat. Severe hyperthermia is not a fever to shrug at — it is a medical emergency in its own right. As muscles work and shiver and seize, they can break down (rhabdomyolysis), spilling myoglobin that clogs the kidneys and precipitates acute kidney injury, alongside dangerous potassium shifts. Uncontrolled, hyperthermia denatures proteins and drives disseminated coagulation and multi-organ failure — which is why cooling is not cosmetic but life-saving. MDMA adds a complication all its own: hyponatraemia. Partly the drug triggers inappropriate ADH release (SIADH), and partly users, warned to stay hydrated while dancing for hours, drink large volumes of plain water; the combination dilutes the blood sodium until the brain swells, causing seizures and cerebral oedema. The mechanism of that dilutional/SIADH hyponatraemia, and MDMA's overlap with serotonin excess, connect to the Lithium and serotonin chapter.
One drug does the work of many antidotes: the benzodiazepine. Because the entire toxidrome is downstream of central sympathetic overdrive, sedating the patient with a benzodiazepine simultaneously calms the agitation, slows the heart, lowers the blood pressure, aborts seizures, and helps bring the temperature down. There is rarely a single "antidote" to titrate against a specific number; instead you turn down the master dial. Give enough, titrated to a calm patient — often far more than you first expect. If benzodiazepines alone won't control a dangerously high pressure, add a direct vasodilator or an alpha-blocker (phentolamine, a nitrate) — not a beta-blocker.
The beta-blocker trap: unopposed alpha
The most famous pitfall in stimulant toxicology is a drug that seems perfectly logical. Faced with a racing, hypertensive heart, giving a beta-blocker looks like textbook good sense. In cocaine toxicity it can be a disaster. Adrenergic stimulation acts on two families of receptor: beta receptors, which (among other things) dilate coronary and peripheral vessels, and alpha receptors, which constrict them. Block the beta receptors with a non-selective agent and you leave the alpha-mediated vasoconstriction with nothing to oppose it — "unopposed alpha stimulation." The coronary vasospasm worsens, ischaemia deepens, and the blood pressure can climb higher still. This is the classic teaching against non-selective beta-blockers (propranolol is the exam villain) in acute cocaine toxicity. The safer path is the one already described: benzodiazepines to dial down the sympathetic drive, and if more is needed, alpha-blockade or direct vasodilators — phentolamine (a pure alpha-blocker) or nitrates for coronary spasm. The alpha-versus-beta logic and the unopposed-alpha concept itself are grounded in the Autonomic nervous system chapter, where phentolamine appears as the prototype alpha-antagonist.
The second cocaine-specific antidote targets the sodium-channel poisoning, not the adrenergic surge. When cocaine's membrane-stabilising effect widens the QRS or provokes ventricular arrhythmia, the treatment is intravenous sodium bicarbonate — exactly as in tricyclic-antidepressant cardiotoxicity. Flooding the system with sodium overcomes the channel blockade and narrows the QRS, while the alkalinising shift further favours the drug's release from the channel. This is a direct echo of the Cardiovascular chapter's teaching on wide-complex, membrane-stabilising cardiotoxicity: whenever a sodium-channel blocker widens the QRS — TCAs, local anaesthetics, cocaine — bicarbonate is the answer.
Benzodiazepine (e.g. diazepam, lorazepam) — the cornerstone; titrate to a calm patient to treat agitation, tachycardia, hypertension, seizures, and to help cooling. Active external cooling — for hyperthermia, the true killer. IV crystalloid fluids — for rhabdomyolysis and to protect the kidneys. Phentolamine or a nitrate (glyceryl trinitrate) — for refractory hypertension or cocaine coronary vasospasm. Sodium bicarbonate — for cocaine-induced wide-QRS / ventricular arrhythmia. And a firm entry on the do-not-give list: non-selective beta-blockers in cocaine toxicity.
- Benzodiazepines are the cornerstone — they calm the whole sympathetic storm at once (agitation, HR, BP, seizures, temperature).
- Hyperthermia is a killer — treat with aggressive active cooling, not just antipyretics.
- Rhabdomyolysis from muscle breakdown needs generous IV fluids to protect the kidneys.
- Avoid non-selective beta-blockers in cocaine toxicity — unopposed alpha worsens vasospasm and hypertension.
- For cocaine wide-QRS/arrhythmia give sodium bicarbonate; for refractory hypertension/spasm give phentolamine or nitrates.
- MDMA hyponatraemia (SIADH + water-drinking) can cause seizures and cerebral oedema — check the sodium.
Body-packers, body-stuffers, and the chronic user
Two special situations turn a poisoning into a surgical problem. Body-packers ("mules") swallow many well-wrapped, high-purity packets to smuggle drug across borders; body-stuffers hastily swallow poorly wrapped supply to hide it from police. Both risk a massive, lethal release if a packet ruptures inside the gut. For the asymptomatic packer, the approach is careful bowel decontamination with whole-bowel irrigation (polyethylene glycol) to move the packets through intact, with imaging to confirm clearance — a specific indication for this rarely used technique. But the moment a patient shows signs of package rupture — a sudden, escalating sympathomimetic storm — it becomes a surgical emergency: no antidote can keep pace with the dose spilling out, and the packets must be removed operatively. Endoscopic retrieval is generally avoided for fear of tearing a packet.
Beyond the acute crisis lies the chronic toll. Repeated stimulant use accelerates atherosclerosis and can leave a young heart with a dilated cardiomyopathy; chronic cocaine erodes the nasal septum; methamphetamine ravages the teeth ("meth mouth") and can drive a lasting psychosis. And there is dependence itself: stimulant use disorder, driven by the dopamine-reward pathway these very drugs hijack. Unlike opioid or alcohol dependence, there is no established, licensed substitution therapy for cocaine or amphetamine addiction — management rests on psychosocial and behavioural treatment, which makes prevention and harm-reduction all the more important.
- Giving a non-selective beta-blocker (e.g. propranolol) to a hypertensive, tachycardic cocaine patient — unopposed alpha stimulation can worsen coronary spasm and drive the pressure higher.
- Treating hyperthermia with paracetamol and a blanket instead of aggressive active cooling — the temperature, not the fever label, is what dissolves muscle and clots blood.
- Mislabelling a sweaty, agitated stimulant patient as anticholinergic (or vice versa) — diaphoresis is the discriminator; the dry patient is anticholinergic, the wet one sympathomimetic.
A 24-year-old man presents agitated and diaphoretic after using cocaine, with crushing chest pain, BP 205/118 and HR 148. The ECG shows ischaemic changes. Which is the single most appropriate initial pharmacological step?
- Stimulants (cocaine blocks monoamine reuptake; amphetamines/cathinones/MDMA release monoamines) cause a sympathomimetic toxidrome: agitated, mydriatic, tachycardic, hypertensive, hyperthermic and — the discriminator — sweaty.
- End-organ harm kills: MI (vasospasm + thrombosis + demand), aortic dissection, intracranial haemorrhage/stroke, hyperthermia with rhabdomyolysis and AKI, and MDMA hyponatraemia.
- Benzodiazepines are the cornerstone — they calm agitation, tachycardia, hypertension, seizures and temperature; add aggressive cooling and IV fluids.
- Avoid non-selective beta-blockers in cocaine toxicity (unopposed alpha); use alpha-blockade/nitrates for pressure, and sodium bicarbonate for cocaine-induced wide-QRS/arrhythmia.
- Goldfrank's Toxicologic Emergencies — Cocaine; Amphetamines; MDMA and hallucinogenic amphetamines.
- Rang & Dale's Pharmacology — CNS stimulants and psychomotor drugs; noradrenergic and dopaminergic transmission.
- Katzung Basic & Clinical Pharmacology — Drugs of abuse; the sympathomimetics.
- McCord J, et al. Management of Cocaine-Associated Chest Pain and Myocardial Infarction — AHA Scientific Statement, Circulation.
- Hoffman RS. Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside. British Journal of Clinical Pharmacology.
- AACT/EAPCCT Position Statement: Whole Bowel Irrigation (body-packer decontamination).
